1 |
Grunkemeier GL, Jamieson WRE, Miller DC, Starr A. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovas Surg 1994;108:709-18
PUBMED
|
2 |
Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1993;113:143-55
|
3 |
Jorge-Herrero E, Fernandez P, Gutierrez M, Castillo-Olivares JL. Study of the calcification of bovine pericardium: analysis of the implication of lipids and proteoglycans. Biomaterials 1991;12:638-89
DOI
ScienceOn
|
4 |
Thomas PJ, James AB, Barbara LC, Frederick JS, Gordon A, Robert JL. Controlled release of ethanehydroxy diphosphonate from polyurethane reservoirs to inhibit calcification of bovine pericardium used in bioprosthetic heart valves. Int J Pharm 1990;59:95-104
DOI
ScienceOn
|
5 |
Hirsch D, Drader J, Yhomas TJ, Schoen FJ, Levy JT, Levy RJ. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies. J Biomed Mater Res 1993;27:1477-84
DOI
ScienceOn
|
6 |
Chanda J. Anticalcification treatment of pericardial prostheses. Biomaterials 1994;15:465-9
DOI
PUBMED
ScienceOn
|
7 |
Ameli E, Yates T, Hymana P, Zilla P. Detoxication on top of enhanced, diamine-etended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in sheep model. J Heart Valve Disease 2003;12:93-101
|
8 |
Eybl E, Grimm M, Grabenwoger M, Bock P, Muller M, Wolner E. Endothelial cell lining of bioprosthetic heart valve materials. J Thorac Cardiovasc Surg 1992;104:763-9
DOI
PUBMED
ScienceOn
|
9 |
Jee KS, Kim YS, Park KD, Kim YH. A novel chemical modification of bioprosthetic tissues using L-arginine. Biomaterials 2003;24:3409-16
DOI
ScienceOn
|
10 |
Maranto A, Schoen F. Alkaline phosphatase activity of glutaraldehyde-treated bovine pericardium used in bioprosthetic cardiac valves. Circ Res 1988;63:844-8
DOI
PUBMED
|
11 |
Connolyy JM, Alferiev I, Kronsteiner A, Lu Z, Robert J. Levy ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride. J Heart Valve Disease 2004;13:487-93
|
12 |
Grabenwoger M, Grimm M, Eybl E, Leukauf C, Plenck H Jr, Bock P. Decreased tissue reaction to bioprosthetic heart valve material after L-giutamic acid treatment. A morphological study. J Biomed Mater Res 1992;26:1231-40
DOI
PUBMED
|
13 |
Moritz A, Grimm M, Eybl E, et al. Improved spontaneous endothelialization by postfixation treatment of bovine pericardium. Eur J Cardiothorac Surg 1991;5:155-60
DOI
ScienceOn
|
14 |
Humana P, Bezuidenhouta D, Torriannib M, Hendriksc M, Zilla P. Optimization of diamine bridges in glutaraldehyde treated bioprosthetic aortic wall tissue. Biomaterials 2002; 23:2099-103
DOI
ScienceOn
|
15 |
Neethling WM, Hodge AJ, Clode P, Glancy R. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium. J Cardiovasc Surg (Torino) 2006;47: 711-8
|
16 |
Zilla P, Weissenstein C, Bracher M, et al. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue. J Heart Valve Dis 1997;6: 502-9
|
17 |
Paul H, Peter Z. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001;71:S385
DOI
ScienceOn
|
18 |
Webb CL, Nguyen NM, Schoen FJ, Levy RJ. Calcification of allograft aortic wall in a rat subdermal model: pathophysiology and inhibition by Al3+ and aminodiphosphonate preincubations. Am J Pathol 1992;141:487-96
|
19 |
Chen W, Scheon FJ, Levy RJ. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde pretreated porcine bioprosthetic heart valves. Circulation 1994;90:323-9
DOI
PUBMED
|
20 |
Kim KC, Choi YK, Kim SH, et al. Effect of diamine bridges using l-lysine in glutaraldehyde treated porcine pericardium. Korean J Thorac Cardiovasc Surg 2009;42:157-64
|
21 |
Kim KC, Lee C, Choi CH, et al. Development of porcine pericardial heterograft for clinical application (tensile strength-thickness). Korean J Thorac Cardiovasc Surg 2008; 41:170-6
|
22 |
Jorge-Herrero E, Fernandez P, Escudero C, Garcia-Paez JM, Castillo-Olivares JL. Calcification of pericardial tissue pretreated with different amino acids. Biomaterials 1996;17: 571-5
DOI
ScienceOn
|
23 |
Nimni WN, Cheung D, Strates B. Chemically modified collagen: a natural biomaterial for tissue replacement. J Biomed Mater Res 1994;15:465-9
DOI
ScienceOn
|
24 |
Pereira CA, Lee JM, Haberer SA. Effect of alternative crosslinkingmethods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 1990;24:345-61
DOI
PUBMED
|
25 |
Lee CH, Vyavahare N, Zand R, et al. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res 1998;42:30-7
DOI
ScienceOn
|
26 |
Schoen FJ, Levy RJ, Piehler HR. Pathological considerations in replacement cardiac valves. Cardiovase Pathol 1992;1:29-52
DOI
ScienceOn
|
27 |
Quesenberry MS, Lee YC. A rapid formaldehyde assay using purpald reagent: application under periodation conditions. Anal Biochem 1996;234:50-5
DOI
ScienceOn
|
28 |
Moritz A, Grimm M, Eybl E, et al. Improved biocompatibility by post fixation treatment of aldehyde fixed bovine pericardium. Trans Am Sot Artif Intern Organs 1990;36: M300-3
|
29 |
Levy RJ, Qu X, Underwood T, Trachy J, Schoen FJ. Calcification of valved aortic allografts in rats: effects of age, crosslinking, inhibitors. J Biomed Mater Res 1995;29:217-26
DOI
ScienceOn
|
30 |
Garcia Paez JM, Jorge-Herrero E, Carrera A, et al. Chemical treatment and tissue selection: factors that influence the mechanical behaviour of porcine pericardium. Biomaterials 2001;22:2759-67
DOI
ScienceOn
|